Abstract
When fetal alcohol syndrome (FAS) was initially described, diagnosis was based upon physical parameters including facial anomalies and growth retardation, with evidence of developmental delay or mental deficiency. Forty years of research has shown that FAS lies towards the extreme end of what are now termed fetal alcohol spectrum disorders (FASD). The most profound effects of prenatal alcohol exposure are on the developing brain and the cognitive and behavioral effects that ensue. Alcohol exposure affects brain development via numerous pathways at all stages from neurogenesis to myelination. For example, the same processes that give rise to the facial characteristics of FAS also cause abnormal brain development. Behaviors as diverse as executive functioning to motor control are affected. This special issue of Neuropsychology Review addresses these changes in brain and behavior highlighting the relationship between the two. A diagnostic goal is to recognize FAS as a disorder of brain rather than one of physical characteristics.
Similar content being viewed by others
References
Aase, J. M., Jones, K., & Clarren, S. K. (1995). Do we need the term “FAE”? Pediatrics, 95(3), 428–430.
Abel, E. L., & Sokol, R. J. (1991). A revised conservative estimate of the incidence of FAS and its economic impact. Alcoholism: Clinical and Experimental Research, 15(3), 514–524.
Astley, S. J. (2004). Diagnostic guide for fetal alcohol spectrum disorders: The 4-digit diagnostic code. 3rd ed. Seattle, WA: University of Washington Publication Services. http://depts.washington.edu/fasdpn/pdfs/guide2004.pdf
Astley, S. J., & Clarren, S. K. (2000). Diagnosing the full spectrum of fetal alcohol-exposed individuals: Introducing the 4-digit diagnostic code. Alcohol and Alcoholism, 35(4), 400–410.
Bertrand, J., Floyd, R. L., Weber, M. K., O’Connor. M., Riley, E. P., Johnson, K. A., et al. (2004). Fetal alcohol syndrome: guidelines for referral and diagnosis. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/ncbddd/fasd/documents/FAS_guidelines_accessible.pdf
Bertrand, J., Floyd, R. L., & Weber, M. K. (2005). Guidelines for identifying and referring persons with fetal alcohol syndrome. Morbidity and Mortality Weekly Report, 54(RR-11), 1–14.
Burd, L., & Hofer, R. (2008). Biomarkers for detection of prenatal alcohol exposure: a critical review of fatty acid ethyl esters in meconium. Birth Defects Research. Part A, Clinical And Molecular Teratology, 82(7), 487–493.
Burd, L., Klug, M., & Martsolf, J. (2004). Increased sibling mortality in children with fetal alcohol syndrome. Addiction Biology, 9(2), 179–186.
Calhoun, F., & Warren, K. (2007). Fetal alcohol syndrome: Historical perspectives. Neuroscience and Biobehavioral Reviews, 31(2), 168–171.
Center for Disease Control and Prevention (CDC). (1993). Fetal alcohol syndrome—United States, 1979–1992. Morbidity and Mortality Reports, 42(17), 339–341.
Center for Disease Control and Prevention (CDC). (1995). Update: Trends in fetal alcohol syndrome—United States, 1979–1993. Morbidity and Mortality Reports, 44(13), 249–51.
Center for Disease Control and Prevention (CDC). (1997). Surveillance for fetal alcohol syndrome using multiple sources—Atlanta, Georgia, 1981–1989. Morbidity and Mortality Reports, 46(47), 1118–20.
Center for Disease Control and Prevention (CDC). (2002). Fetal alcohol syndrome—Alaska, Arizona, Colorado, and New York, 1995–1997. Morbidity and Mortality Reports, 51(20), 433–435.
Chudley, A. E., Conry, J., Cook, J. L., Loock, C., Rosales, T., & LeBlanc, N. (2005). Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. Canadian Medical Association Journal, 172(5 Suppl), S1–S21.
Clarren, S. K., & Smith, D. W. (1978). The fetal alcohol syndrome. The New England Journal of Medicine, 298(19), 1063–1067.
Clarren, S. K., Chudley, A. E., Wong, L., Friesen, J., & Brant, R. (2010). Normal distribution of palpebral fissure lengths in Canadian school age children. Canadian Journal of Clinical Pharmacology, 17, e67–e78.
Datta, S., Turner, D., Singh, R., Ruest, L. B., Pierce, W. M., Jr., & Knudsen, T. B. (2008). Fetal alcohol syndrome (FAS) in C57BL/6 mice detected through proteomics screening of the amniotic fluid. Birth Defects Research Part A, Clinical and Molecular Teratology, 82(4), 177–186.
Garcia-Algar, O., Kulaga, V., Gareri, J., Koren, G., Vall, O., Zuccaro, P., et al. (2008). Alarming prevalence of fetal alcohol exposure in a Mediterranean city. Therapeutic Drug Monitoring, 30(2), 249–254.
Gareri, J., Lynn, H., Handley, M., Rao, C., & Koren, G. (2008). Prevalence of fetal ethanol exposure in a regional population-based sample by meconium analysis of fatty acid ethyl esters. Therapeutic Drug Monitoring, 30(2), 239–45.
Gifford, A. E., Farkas, K. J., Jackson, L. W., Molteno, C. D., Jacobson, J. L., Jacobson, S. W., et al. (2010). Assessment of benefits of a universal screen for maternal alcohol use during pregnancy. Birth Defects Research. Part A, Clinical and Molecular Teratology, 88(10), 838–846.
Goh, Y. I., Hutson, J. R., Lum, L., Roukema, H., Gareri, J., Lynn, H., et al. (2010). Rates of fetal alcohol exposure among newborns in a high-risk obstetric unit. Alcohol (Fayetteville, N.Y.), 44(7–8), 629–634.
Goodlett, C. R., Horn, K. H., & Zhou, F. C. (2005). Alcohol teratogenesis: mechanisms of damage and strategies for intervention. Experimental Biology And Medicine (Maywood, N.J.), 230(6), 394–406.
Hall, J. G. (2010). New palpebral fissure measurements. American Journal of Medical Genetics Part A, 152A, 1870.
Hall, J. G., Froster-Iskenius, U. G., & Allanson, J. E. (1989). Handbook of Normal Physical Measurements. New York: Oxford University Press.
Harlap, S., & Shiono, P. H. (1980). Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. Lancet, 2, 173–176.
Hoyme, H. E., May, P. A., Kalberg, W. O., Kodituwakku, P., Gossage, J. P., Trujillo, P. M., et al. (2005). A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 Institute of Medicine criteria. Pediatrics, 115(1), 39–47.
Hutson, J., Magri, R., Gareri, J., & Koren, G. (2010). The incidence of prenatal alcohol exposure in Montevideo Uruguay as determined by meconium analysis. Therapeutic Drug Monitoring, 32(3), 311–317.
Jones, K. L., & Smith, D. W. (1973). Recognition of the fetal alcohol syndrome in early infancy. Lancet, 2(7836), 999–1001.
Jones, K. L., Smith, D. W., Ulleland, C. N., & Streissguth, A. P. (1973). Pattern of malformation in offspring of chronic alcoholic mothers. Lancet, 1(7815), 1267–1271.
Jones, K. L., Smith, D. W., & Hanson, J. W. (1976). The fetal alcohol syndrome: clinical delineation. Annals of the New York Academy of Sciences, 273, 130–139.
Kline, J., Shrout, P., Stein, Z., Susser, M., & Warburton, D. (1980). Drinking during pregnancy and spontaneous abortion. Lancet, 2(8187), 176–180.
Kulaga, V., Shor, S., & Koren, G. (2010). Correlation between drugs of abuse and alcohol by hair analysis: parents at risk for having children with fetal alcohol spectrum disorder. Alcohol (Fayetteville, N.Y.), 44(7–8), 615–621.
Lupton, C., Burd, L., & Harwood, R. (2004). Cost of fetal alcohol spectrum disorders. American Journal of Medical Genetics Part C (Seminars in Medical Genetics), 127C(1), 42–50.
May, P. A., & Gossage, J. P. (2001). Estimating the prevalence of fetal alcohol syndrome: a summary. Alcohol Research and Health, 25(3), 159–167.
May, P. A., Fiorentino, D., Gossage, J. P., Kalberg, W. O., Hoyme, H. E., Robinson, L. K., et al. (2006). Epidemiology of FASD in a province in Italy: Prevalence and characteristics of children in a random sample of schools. Alcoholism, Clinical and Experimental Research, 30(9), 1562–1575.
May, P. A., Gossage, J. P., Marais, A., Adnams, C. M., Hoyme, H. E., Jones, K. L., et al. (2007). The epidemiology of fetal alcohol syndrome and partial FAS in a South African community. Drug and Alcohol Dependence, 88(2–3), 259–271.
May, P. A., Gossage, J. P., Kalberg, W. O., Robinson, L. K, Buckley, D., Manning, M., et al. (2009). Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies. Developmental Disabilities Research Reviews, 15(3), 176–192.
Olson, H. C., Ohlemiller, M. M., O’Connor, M. J., Brown, C. W., Morris, C. A., & Damus, K., National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect. (2009). A call to action: Advancing Essential Services and Research on Fetal Alcohol Spectrum Disorders—A report of the National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect, March 2009. www.cdc.gov/ncbddd/fas.
Petković, G., & Barisić, I. (2010). FAS prevalence in a sample of urban schoolchildren in Croatia. Reproductive Toxicology, 29(2), 237–241.
Sampson, P. D., Streissguth, A. P., Bookstein, F. L., Little, R. E., Clarren, S. K., Dehaene, P., et al. (1997). Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology, 56(5), 317–326.
Sokol, R. J., Delaney-Black, V., & Nordstrom, B. (2003). Fetal alcohol spectrum disorder. JAMA: The Journal of the American Medical Association, 290(22), 2996–2999.
Spohr, H. L., & Steinhausen, H. C. (2008). Fetal alcohol spectrum disorders and their persisting sequelae in adult life. Deutsches Ärzteblatt International, 105(41), 693–698.
Stade, B., Ali, A., Bennett, D., Campbell, D., Johnston, M., Lens, C., et al. (2009). The burden of prenatal exposure to alcohol: revised measurement of cost. Canadian Journal of Clinical Pharmacolology, 16(1), e91–e102.
Stratton, K., Howe, C., & Battaglia, F. (1996). Fetal alcohol syndrome: Diagnosis, epidemiology, prevention, and treatment. Washington, DC: National Academy.
Thomas, L. T., Gaitantzis, Y. A., & Frias, J. L. (1987). Palpebral fissure length from 29 weeks to 14 years. Journal of Pediatrics, 111(2), 267–268.
Acknowledgements
The authors greatly acknowledge the help of Jason Dudley and Kristen Breit in preparing the figure for this manuscript. Preparation of this paper was supported by National Institute of Health NIAAA Grants R01 AA010417, U24 AA014811, and T32 AA013525 to epr. and was conducted in conjunction with the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD). More information about the CIFASD can be found at www.cifasd.org
Disclosure
The authors have no financial relationships to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riley, E.P., Infante, M.A. & Warren, K.R. Fetal Alcohol Spectrum Disorders: An Overview. Neuropsychol Rev 21, 73–80 (2011). https://doi.org/10.1007/s11065-011-9166-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11065-011-9166-x